About

Krishnendu Khan, PhD, leads the Advanced Therapies, Innovation & Strategic Partnerships team at West. In his role, he acts as a subject matter expert in primary packaging and administration for cell and gene therapies, leading West’s strategic initiatives in this rapidly evolving field. Dr Khan received his PhD in Biochemistry from the Indian Institute of Science in Bengaluru, India, followed by postdoctoral research appointments in Germany and the US. Prior to joining West, he contributed to advancing and commercialising innovative biologics and diagnostic technologies.